Advertorial, B. (2017). Advertorial: EMA REAFFIRMS POSITIVE BENEFIT-RISK BALANCE OF BAYER’S XARELTO® FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION. SA Heart Journal, 13(1), 42–43. https://doi.org/10.24170/13-1-1694